Business Insider is reporting that as news that Donald Trump will be the 45th president sent stocks into an early Thursday tumble in Europe, by around 9:50 a.m. in London (4:50 a.m. EST), pharmaceutical stocks were rising, with Hikma Pharmaceuticals’s stock up 6% on the FTSE 100. Roche and Novartis saw stock increases over 4% and GSK saw a 1.8% bump. Jefferies pointed to hope that efforts to enact new pricing rules on drugs led the swell, telling Business Insider, “Sentiment towards the Healthcare sector ought to swing initially away from draconian fears over drug pricing.” (Business Insider)
Under the agreement, AstraZeneca will continue to manufacture and supply the drug and its authorized generic to Aralex Ireland for at least 10 years, and it will continue to distribute the product until it is transferred, which could be up to nine months after closing.
Restasis Multidose has a unidirectional valve and air filter technology that the company says eliminates the need for a preservative, and the bottle uses less plastic than a package of single-use vials.